Lupher, Jr. Mark L. 4
4 · Adverum Biotechnologies, Inc. · Filed Aug 2, 2019
Insider Transaction Report
Form 4
Lupher, Jr. Mark L.
Director
Transactions
- Award
Stock Option (Right to Buy)
2019-07-31+11,250→ 11,250 totalExercise: $13.41Exp: 2029-07-30→ Common Stock (11,250 underlying)
Footnotes (1)
- [F1]The shares subject to the option will vest on the earlier of (a) the 2020 annual meeting of stockholders and (b) July 31, 2020.